Hythiam, Inc. provides through its Catasys subsidiary, specialized behavioral health management services to health plans, employers and unions through a network of licensed and company managed health care providers. The Catasys substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to lower costs and improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term care coaching, including the proprietary PROMETA® Treatment Program for alcoholism and stimulant dependence. The PROMETA Treatment Program, which integrates behavioral, nutritional, and medical components, is also available on a private-pay basis through licensed treatment providers.

CATASYS^®, our Integrated Substance Dependence Solution, is the only program of its kind dedicated exclusively to chemical dependence. Catasys integrates medical and behavioral therapies to help your organization treat and manage your substance dependent population to impact both the medical and behavioral health costs associated with substance-dependence and the related co-morbidities.

>> More about Catasys